Single Cell Genomics Market Assessment

Single Cell Genomics Market Assessment

Abstract

Single-cell genomics (SCG) is a fast growing and now increasingly more established approach in which genomic technologies (i.e., that assess nucleic acids such as DNA or RNA) are applied at the level of single-cells, rather than at the level of an entire cell population.

The fourth edition of this report reviews the market size, segmentation, growth and trends of the SCG market. We assess the SCG market across 7 segments and 33 subsegments: customer (e.g., academia, biopharma, applied markets, clinical), workflow step (e.g., cell isolation, sample preparation, genomic analysis), analytical technology (e.g., PCR, qPCR, microarray, next-generation-sequencing, other), field-of-study (e.g., oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other), application (e.g., genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation / reprograming, method, other), product type (e.g., instruments, reagents) and geography (e.g., U.S., Europe, Japan, China, Asia-Pacific, ROW). For each of these segments, we provide an estimated market size and growth from 2015 to 2023, as well as key growth drivers and moderators.

We review key factors driving future growth including 1) Increasing commercial availability of new applications beyond RNA-seq, including multiomics (e.g., ATAC-seq, CITE-seq) and functional assays, 2) 10X Genomics driving additional applications on large and growing install base, 3) Large-scale, well-funded initiatives, like the Human Cell Atlas, 4) New instruments that can automate and optimize the solid tissue to cells/nuclei suspension preparation, feeding high-throughput machines. On the other hand, we discuss key factors moderating growth including 1) Challenges in data analysis and data integration as the single-cell study sizes increase and single-cell multiomics interest grows, 2) High sequencing cost relative to prior analytical technologies.

In addition, we include output from a primary research campaign across 25 single-cell researchers in academia, biopharma, and clinical settings. We capture current and anticipated spend, analyte trends (e.g., RNA, DNA, multiomics), platform acquisition trends (i.e., plans on buying additional instruments), and purchasing criteria.

PURCHASE THE REPOrt

Author: Miguel Edwards

Date: April 14, 2020

Pages: 146 pages

Price: $5500

  • Select SCG Companies

    single cell genomics Logos

  • Major Trends
    Drivers
    • Increasing commercial availability of new applications including multiomics (e.g., ATAC-seq, CITE-seq) and functional assays
    • 10X Genomics driving additional applications on large and growing install base
    • Large-scale, well-funded initiatives, like the Human Cell Atlas
    • Pharma interest in single-cell methods to boost drug discovery (e.g., Takeda, Kite Pharma, and Janssen all have a partnership with single-cell companies)
    • New instruments (e.g., S2 Genomics’ Singluator) that can automate and optimize the solid tissue to cells/nuclei suspension preparation, feeding high-throughput machines
      Key Moderators
    Moderators
    • Challenges in data analysis and data integration as the interest in single-cell multiomics grows
    • High sequencing cost relative to prior analytical technologies
    • Lack of sensitivity as whole transcriptome approaches only capture a portion of the total expressed genes
    • Limited short-term clinical applications
  • Report Segmentations

    Buyers of SCG instruments, reagents, and consumables from manufacturers

    • Academia
    • Biopharma
    • Clinical
    • Applied Markets
    • Others

    Type of a platform that manufacturer sells to its customers, based on throughout

    • Microbiology
    • Basic cell biology
    • Stem cell biology
    • Oncology
    • Immunology
    • Non-specific
    • Other

    Country / region of the world

    • U.S.
    • Europe
    • Japan
    • China
    • Asia Pacific (APAC)
    • Rest-of-the-world (ROW)

    Individual steps in the SCG analysis process starting from sample and ending with data

    • Single cell isolation
    • Sample preparation
    • Genomic analysis

    Key scientific research question being investigated

    • Subpopulation characterization
    • Genomic variation
    • Cell differentiation/ reprogramming
    • Method
    • Circulating cells
    • Others

    Companies that offer SCG products

    • 10X Genomics
    • 1CellBio
    • BD
    • Berkeley Lights
    • Bio-Rad
    • Celsee
    • Dolomite Bio
    • Illumina
    • Mission Bio
    • Takara Bio
    • Fluidigm
    • Others

    Genomic technology used to quantify and / or identify the DNA / RNA of each single cell

    • qPCR
    • Sequencing
    • PCR
    • Multiple
    • Microarray
    • Other

    Type of product that manufacturer sells to its customers

    • Instruments
    • Reagents
  • Table of Contents
  • Related Reports

LEAD AUTHOR | MIGUEL EDWARDS, PHD

Miguel Edwards is a Senior Project Leader at DeciBio, with 5 years of strategy consulting experience. Miguel has worked on several engagements identifying industry trends in the life-science research tools and clinical diagnostics spaces. Miguel has extensively researched the market for novel, disruptive diagnostic technologies, including digital biomarkers, liquid biopsies, multi-omics, and single-cell platforms. Miguel has conducted >100 interviews with single-cell researchers and KOLs for strategy consulting cases.

Connect with Miguel on LinkedIn today!